In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

New plan backs researchers to seize on new and developing opportunities to phase out animal tests with specific commitments for the coming years. Animal testing in science is set to be phased out ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...

Add Yahoo as a preferred source to see more of our stories on Google. A vast number of chemicals are registered for production and use around the world. But only a portion have been thoroughly ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced plans in 2025 to reduce animal testing requirements in biomedical research. New approach ...

In a Policy Forum, Chad Nelson and colleagues highlight the efforts of the U.S. Food and Drug Administration (FDA) in advancing alternative methods to reduce animal testing for regulatory use. Animal ...

Add Yahoo as a preferred source to see more of our stories on Google. Governments have announced plans to reduce the number of animals, such as mice, used in experimental procedures. (Philip Cheung ...